Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE2
60 participants
INTERVENTIONAL
2004-03-31
2007-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Early Short-term Training on Thrombogenesis in Patients Following Coronary Bypass Surgery
NCT02144480
Exercise-training Before Coronary Artery Bypass Graft (CABG)
NCT00218985
High Intensity Training in de Novo Heart Transplant Recipients in Scandinavia
NCT01796379
Effects of Exercise Training on Left Ventricular Function in Type 2 Diabetic Patients Post Coronary Artery Bypass Graft
NCT00172536
Effects of Exercise Training on Vascular Endothelial Function of Patients Submitted to Coronary Artery Bypass Graft
NCT02265107
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The subjects in this study is attending a four week rehabilitation program at an residential institution in Norway. They are randomised to do either a moderate or a high intensity aerobic training session each day.
The hypothesis in advance, was that high intensity interval training lead to a greater improvement in maximal oxygen consumption than training with moderate intensity. We also hypothesised that there would be no difference between the two groups after 6 months, since then the patients had to administer their own exercise training.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A
Interval exercise training with high intensity
Exercise training
Interval exercise training with high intensity five days per week for four weeks.
B
Exercise training with moderate intensity
Exercise training
Exercise training with moderate intensity, five days per week for four weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exercise training
Interval exercise training with high intensity five days per week for four weeks.
Exercise training
Exercise training with moderate intensity, five days per week for four weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Left ventricle ejection fraction \< 30%
* hemodynamic significant valve deficit (\> NYHA classification II)
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stiftelsen Helse og Rehabilitering
OTHER
Landsforeningen for hjerte og lungesyke (LHL)
UNKNOWN
Røros Rehabiliteringssenter
UNKNOWN
St. Olavs Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Norwegian University of Science and Technology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stig A Slørdahl, Dr.med
Role: STUDY_CHAIR
NTNU, Institutt for sirkulasjon og bildediagnostikk
Trine T Moholdt, MS
Role: PRINCIPAL_INVESTIGATOR
NTNU, Institutt for sirkulasjo og bildediagnostikk
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Norwegian University of Science and Technology
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BypassRoros1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.